Boston, MA -- (SBWIRE) -- 08/21/2013 -- At winstonsmallcap.com we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. Let have a Look on: (Lightinthebox Holding Co Ltd-ADR(NYSE:LITB), Direxion Daily Small Cap Bear 3X Shares(NYSEARCA:TZA), Barnes & Noble, Inc.(NYSE:BKS), MannKind Corporation(NASDAQ:MNKD)
Lightinthebox Holding Co Ltd-ADR(NYSE:LITB) shares decreased 39.91% to $11.58. Lightinthebox Holding Co., Ltd. is a global online retail company that delivers products directly to consumers globally. The Company offers a selection of lifestyle products through www.lightinthebox.com, www.miniinthebox.com and other Websites, which are available in 17 languages.
Is LITB A Strong Buy? Get Advantage Of Our Free Trend Analysis Here
Direxion Daily Small Cap Bear 3X Shares(NYSEARCA:TZA) shares lost 4.47% to $26.51. Direxion Daily Small Cap Bear 3X Shares (the Fund), formerly Direxion Small Cap Bear 3X Shares, seeks daily investment results of 300% of the inverse (or opposite) of the price performance of the Russell 2000 Index (the Small Cap Index). The Small Cap Index measures the performance of the small-cap segment of the United States equity universe and consists of the smallest 2,000 companies in the Russell 3000 Index, representing approximately 10% of the total market capitalization of the Russell 3000 Index.
Is TZA A Good Buy After The Recent Price Movement? Find Out Here
Barnes & Noble, Inc.(NYSE:BKS) shares decreased 12.36% to $14.61. Barnes & Noble, Inc. (Barnes & Noble) is a bookseller. The Company is a content, commerce and technology company that provides customers access to books, magazines, newspapers and other content across its multi-channel distribution platform. As of April 28, 2012, it operated 1,338 bookstores in 50 states, 647 bookstores on college campuses, and operates one of the Web eCommerce sites, and develops digital content products and software.
How Should Investors Trade BKS After The Recent Volatility? Get Free Report Here
MannKind Corporation(NASDAQ:MNKD) shares declined 4.85% to $6.06. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia.
How Should Investors Trade MNKD After The Recent Volatility? Get Free Report Here
Here at Winston we focus on undervalued companies trading under $5. Right now the markets are surging and we are seeing an opportunity in micro-cap companies like we have never seen before. We focus on companies that we feel are trading at a discount to the market for various reasons. Enter your email and track our performance! We are sure you won’t be disappointed.
http://winstonsmallcap.com/and its owners, and their affiliates, directors and officers, and immediate family members, are hereafter collectively referred to as “WSC” or “we” or “us” or “our”). WSC publishes information (the “Information”) about publicly traded companies (the “Profiled Company” or the “Profiled Companies”) which has been obtained from various sources including publicly available sources on the internet. WSC does not undertake any due diligence or investigation of the Information it obtains or publishes.
Read Full Disclaimer at: http://winstonsmallcap.com/disclaimer
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)